Precision BioSciences Announces Senior Leadership Changes
Precision BioSciences (NASDAQ: DTIL) has announced a reorganization within its senior leadership team as the company moves forward with advancing its key clinical programs. Alex Kelly, currently serving as Chief Financial Officer, will be promoted to the newly created role of Chief Operating Officer. In this new position, he will oversee critical customer-facing functions. The changes reflect an internal restructuring aimed at strengthening operational and strategic execution for Precision BioSciences' gene-editing initiatives. The company is preparing to scale its operations as it progresses with clinical development plans.
Tickers: $DTIL
Topics: executive promotion leadership change